| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |